Toggle light / dark theme

Chinese scientists report gene editing tool better than CRISPR

The new tool has the capacity to undertake strand-specific gene editing without any cuts.

Chinese researchers claim to have created a new gene-editing technique called CyDENT that is more effective than Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology.

This is according to a report by the South China Morning Post (SCMP) published on Saturday.

The cutting-edge gene-editing technique CRISPR enables precise DNA changes within an organism’s genome. Its development in the past few years has significantly advanced genetic engineering and biotechnology.

Accomplished Surgeons Doing Robotic Surgery Recorded a 5X Growth in India

As the Indian healthcare sector increasingly adopts robotic surgery, Dr. Mahendra Bhandari, the CEO of the US-based Vattikuti Foundation and a prominent advocate for robotic surgery, highlights the growing presence of various surgical robots from multiple vendors. He underscores the rising number of trained doctors and the commitment of both government and corporate hospitals to invest in surgical robots across the country.

The Vattikuti Foundation, founded by Indian American entrepreneur and philanthropist Raj Vattikuti, serves communities in Michigan, USA, and India. It initiated the Vattikuti Urology Institute at Henry Ford Health in Detroit, Michigan, in 1997 and has since evolved into an international organisation promoting excellence in robotic surgery through various avenues.

In an exclusive interview Dr. Jayati Dubey, DHN, speaks to Dr. Bhandari on the expanding scope of robotic surgery in India.

Calorie Restriction, Exercise, And Longevity: Luigi Fontana, MD PhD

Join us on Patreon! https://www.patreon.com/MichaelLustgartenPhD

Discount Links:
Oral Microbiome: https://www.bristlehealth.com/?ref=michaellustgarten.
Enter Code: ConquerAging.

At-Home Metabolomics: https://www.iollo.com?ref=michael-lustgarten.
Use Code: CONQUERAGING At Checkout.

NAD+ Quantification: https://www.jinfiniti.com/intracellular-nad-test/
Use Code: ConquerAging At Checkout.

Epigenetic Testing: https://trudiagnostic.com/?irclickid=U-s3Ii2r7xyIU-LSYLyQdQ6…M0&irgwc=1
Use Code: CONQUERAGING

At-Home Blood Testing (SiPhox Health): https://getquantify.io/mlustgarten.

AI Hospitals: A Step Towards the Future — Science View

That’s perfect and from one of the most technological countries. It’s late and I saved it for watching later but I can imagine what is in this video. AI is always useful especially in medicine.


[Skip Intro] 0:22
Learn more about science on NHK WORLD-JAPAN:
https://www3.nhk.or.jp/nhkworld/en/ondemand/category/23/?cid…9-sv303-hp.
More quality content available on NHK WORLD-JAPAN:
https://www3.nhk.or.jp/nhkworld/en/ondemand/video/?cid=wohk-yt-2309-sv303-hp.

The integration of artificial intelligence into healthcare seeks to reduce diagnosis errors while increasing humanity.

The Immortals: meet the billionaires forking out for eternal life

The Conboys’ statement on plasma dilution is important:

The pair are quick to add that this isn’t going to have a Benjamin Button effect, and the research “wasn’t geared to make old people young” – even if this idea is being bio-hacked around the world. “It was clear that there were improvements after a couple of procedures,” says Irina. “[But] it’s not really healthy or rejuvenating to drain somebody of 70% of their blood and replace it with something.” She warns people to wait until more research is done.

Still, they believe that in the next five years we will see huge advancements in prolonging life treatments – including taking a pill instead of getting blood, and a “fountain of middle age”. “People will be able to have this high quality, productive life where they are healthy for many more decades,”


A fascinating and often terrifying new podcast delves into the lengths ‘longevity superstars’ will go to make 90 the new 50, from swapping blood with the young to designing the first ‘post-humans’

NTx Awarded Contract to Demonstrate Novel RNA Vaccine Production Platform

BARDA is part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services.

The NTxscribe platform is a cell-free, continuous flow manufacturing system that reportedly delivers scalable RNA (including mRNA and self-amplifying RNA) materials in a tabletop footprint. This enzymatic process is designed to provide a low cost and rapidly deployable, vertically integrated manufacturing system, according to Jamie Coffin, PhD, CEO of NTx. Through this program, the system is being evaluated for its express development of RNA vaccines and therapeutics for infectious diseases, as well as its capability for distributed biomanufacturing.

“The traditional batch processes for developing vaccines and other biologics are burdensome and cannot be scaled quickly in the event of an emergency,” said Coffin. “Over the course of this project, we will aim to prove that NTxscribe can help BARDA meet its goals toward decentralized and rapidly deployable vaccine manufacturing.”

Most Brain Aneurysms Don’t Cause Symptoms

You could be walking around with an unruptured brain aneurysm. But don’t panic – the Brain Aneurysm Foundation estimates that about 1 in 50 people in the U.S. has an unruptured brain aneurysm. Director of Endovascular Neurosurgery Koji Ebersole, MD, says people are surprised to learn that the majority of aneurysms don’t cause any symptoms.

An aneurysm develops when a vessel in the brain has a thin spot, which then fills with blood, creating a bulge or balloon shape. Most brain aneurysms are small, about the size of a pea. Because the brain itself has no sensory fibers, there is no pain and the brain doesn’t register that the aneurysm is there.

“Most patients find out they have an aneurysm for a completely unrelated reason,” Dr. Ebersole says. “Maybe they’re having trouble with their sinuses and have a CT scan and the doctors find an aneurysm. When you learn you have an aneurysm, it’s important to meet with a physician who’s practiced in neurology to talk about the implications.”

Local surgeon performs first-of-its-kind surgery that could change landscape for transplant patients

Can stem cells block organ transplant rejection?


Organ transplant patients traditionally go through a grueling journey post operation, which involves a copious amount of medication for life. After years of research, Dr. Jeffrey Veale has performed a first-of-its kind surgery that could entirely change the landscape for patients. Rudabeh Shahbazi reports.